Quoin Pharmaceuticals, Ltd. (QNRX)
2025-06-30 | |
|---|---|
| General and administrative | 1,742,594 |
| Research and development | 2,050,585 |
| Total operating expenses | 3,793,179 |
| Unrealized loss | -6,004 |
| Realized and accrued interest income | 103,245 |
| Total other income | 97,241 |
| Net loss | -3,695,938 |